Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome
Clinical trial NCT03113695 · COMPLETED
Trial details
- NCT number
- NCT03113695
- Sponsor
- University of California, San Diego
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2022-05-02
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.